RMD: ResMed Inc. Company Profile & Statistics

About

ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment.

Info & Links

CEO

Michael J. Farrell

Headquarters

9001 SPECTRUM CENTER BLVD.
SAN DIEGO, CA 92123, UNITED STATES

Auditor

KPMG LLP

Share holders

Employees

9,980

ResMed Inc. Statistics

Valuation Measures

Market Capitalization²

34.79B

Enterprise Value

34.94B

Enterprise Value/EBITDA(ttm)

19.64

Price to Earnings Ratio(ttm)

26.33

Price to Sales(ttm)

6.94

Price to Book(mrq)

6.51

Price to Cash(ytd)

25.23

Profitability

Gross Margin(ttm)

58.39%

Operating Margin(ttm)

26.48%

Profit Margin(ttm)

25.33%

Return on Equity(ttm)

26.17%

Return on Invested Capital(ttm)

21.73%

Return on Assets(ttm)

18.60%

Income Statement

Revenue(ttm)

4.93B

Revenue Per Share(ttm)

33.55

Gross Profit(ttm)

2.88B

EBITDA(ttm)³

1.78B

Net Income Available to Common(ttm)

1.25B

Diluted EPS(ttm)

8.47

Share Statistics

Beta (5Y Monthly)

0.70

52-Week Change

10.88%

S&P 500 52-Week Change

12.12%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

146.87M

Dividend Yield

0.91%

Float⁴

145.82M

% Held by Insiders

0.71%

% Held by Institutions

54.98%

Balance Sheet

Total Cash(mrq)

521.94M

Total Cash Per Share(mrq)

3.55

Total Debt(mrq)

672.76M

Total Debt/Equity(mrq)

12.81%

Current Ratio(mrq)

3.33%

Quick Ratio(mrq)

2.29%

Book Value Per Share(mrq)

35.77

Cash Flow

Operating Cash Flow Per Share(ytd)

4.30

Free Cash Flow(ytd)

595.68M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

RMD

ResMed Inc.

ResMed Inc. Profile